| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Jens Kuhle, Christoph Pohl, Matthias Mehling, Gilles Edan, Mark S Freedman, Hans-Peter Hartung, Chris H Polman, David H Miller, Xavier Montalban, Frederik Barkhof, Lars Bauer, Susanne Dahms, Raija Lindberg, Ludwig Kappos, Rupert Sandbrin. Lack of association between antimyelin antibodies and progression to multiple sclerosis. The New England journal of medicine. vol 356. issue 4. 2007-01-30. PMID:17251533. |
an increased risk of progression to clinically definite multiple sclerosis in patients with serum antibodies against myelin oligodendrocyte glycoprotein (mog) and myelin basic protein (mbp) has been reported. |
2007-01-30 |
2023-08-12 |
Not clear |
| Dun Zhou, Rajneesh Srivastava, Stefan Nessler, Verena Grummel, Norbert Sommer, Wolfgang Brück, Hans-Peter Hartung, Christine Stadelmann, Bernhard Hemme. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. vol 103. issue 50. 2007-01-22. PMID:17142321. |
identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. |
2007-01-22 |
2023-08-12 |
rat |
| Nicholas D Huntington, Ryo Tomioka, Chelsea Clavarino, Anne M Chow, David Liñares, Paula Maña, Jamie Rossjohn, Teresa G Cachero, Fang Qian, Susan L Kalled, Claude C A Bernard, Hugh H Rei. A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses. International immunology. vol 18. issue 10. 2007-01-16. PMID:16914508. |
using a b and t cell-mediated mouse model of multiple sclerosis (ms), myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae), we observed that a baff/april antagonist (soluble bcma-fc) inhibited central nervous system inflammation and demyelination such that it suppressed the onset and progression of clinical symptoms of eae. |
2007-01-16 |
2023-08-12 |
mouse |
| Yueting Zhang, Carla Taveggia, Carmen Melendez-Vasquez, Steven Einheber, Cedric S Raine, James L Salzer, Celia F Brosnan, Gareth R Joh. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 26. issue 47. 2006-12-15. PMID:17122042. |
mechanisms that regulate oligodendrocyte survival and myelin formation are an intense focus of research into myelin repair in the lesions of multiple sclerosis (ms). |
2006-12-15 |
2023-08-12 |
human |
| Haiyan Li, Yunhua Mei, Ying Wang, Lingyun X. Vasoactive intestinal polypeptide suppressed experimental autoimmune encephalomyelitis by inhibiting T helper 1 responses. Journal of clinical immunology. vol 26. issue 5. 2006-12-01. PMID:16964563. |
in this study, we used myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (eae) model in c57bl/6 mice to investigate the potential effects of vip on multiple sclerosis. |
2006-12-01 |
2023-08-12 |
mouse |
| Arthur M But. Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology. Glia. vol 54. issue 7. 2006-11-24. PMID:17006895. |
significantly, atp- and glutamate-mediated ca(2+) signaling are also major components of oligodendrocyte and myelin damage in numerous pathologies, most notably ischemia, injury, periventricular leukomalacia, and multiple sclerosis. |
2006-11-24 |
2023-08-12 |
Not clear |
| David Pleasure, Athena Soulika, Sunit K Singh, Vittorio Gallo, Peter Bannerma. Inflammation in white matter: clinical and pathophysiological aspects. Mental retardation and developmental disabilities research reviews. vol 12. issue 2. 2006-11-14. PMID:16807906. |
multiple sclerosis (ms) is an inflammatory white matter disease that often begins in young adulthood, causes multifocal destruction of mature oligodendroglia and of axons, and eventually leads to substantial cumulative neurological disability. |
2006-11-14 |
2023-08-12 |
Not clear |
| Laurent Nguyen, Laurence Borgs, Renaud Vandenbosch, Jean-Marie Mangin, Pierre Beukelaers, Gustave Moonen, Vittorio Gallo, Brigitte Malgrange, Shibeshih Belache. The Yin and Yang of cell cycle progression and differentiation in the oligodendroglial lineage. Mental retardation and developmental disabilities research reviews. vol 12. issue 2. 2006-11-14. PMID:16807909. |
in white matter disorders such as leukodystrophies (ld), periventricular leucomalacia (pvl), or multiple sclerosis (ms), the hypomyelination or the remyelination failure by oligodendrocyte progenitor cells involves errors in the sequence of events that normally occur during development when progenitors proliferate, migrate through the white matter, contact the axon, and differentiate into myelin-forming oligodendrocytes. |
2006-11-14 |
2023-08-12 |
Not clear |
| Tina M Calderon, Eliseo A Eugenin, Lillie Lopez, Sridhar Sampath Kumar, Joseph Hesselgesser, Cedric S Raine, Joan W Berma. A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. Journal of neuroimmunology. vol 177. issue 1-2. 2006-10-26. PMID:16782208. |
the pathogenic mechanisms that contribute to multiple sclerosis (ms) include leukocyte chemotaxis into the central nervous system (cns) and the production of inflammatory mediators, resulting in oligodendrocyte damage, demyelination, and neuronal injury. |
2006-10-26 |
2023-08-12 |
human |
| Joris Vanderlocht, Jerome J A Hendriks, Koen Venken, Piet Stinissen, Niels Helling. Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls. Journal of neuroimmunology. vol 177. issue 1-2. 2006-10-26. PMID:16797728. |
in multiple sclerosis (ms), oligodendrocyte injury is believed to be caused by an aberrant immune response initiated by autoreactive t cells. |
2006-10-26 |
2023-08-12 |
Not clear |
| Heather C Wilson, Neil J Scolding, Cedric S Rain. Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. Journal of neuroimmunology. vol 176. issue 1-2. 2006-09-29. PMID:16753227. |
co-expression of pdgf alpha receptor and ng2 by oligodendrocyte precursors in human cns and multiple sclerosis lesions. |
2006-09-29 |
2023-08-12 |
human |
| D Merkler, B Schmelting, B Czéh, E Fuchs, C Stadelmann, W Brüc. Myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern II multiple sclerosis lesions. Multiple sclerosis (Houndmills, Basingstoke, England). vol 12. issue 4. 2006-09-21. PMID:16900750. |
myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the common marmoset reflects the immunopathology of pattern ii multiple sclerosis lesions. |
2006-09-21 |
2023-08-12 |
monkey |
| Jorge Correale, Silvia N Tenembau. Myelin basic protein and myelin oligodendrocyte glycoprotein T-cell repertoire in childhood and juvenile multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England). vol 12. issue 4. 2006-09-21. PMID:16900754. |
myelin basic protein and myelin oligodendrocyte glycoprotein t-cell repertoire in childhood and juvenile multiple sclerosis. |
2006-09-21 |
2023-08-12 |
Not clear |
| Michael Khalil, Markus Reindl, Andreas Lutterotti, Bettina Kuenz, Rainer Ehling, Claudia Gneiss, Peter Lackner, Florian Deisenhammer, Thomas Berge. Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments. Journal of neuroimmunology. vol 174. issue 1-2. 2006-07-06. PMID:16516980. |
only few reports are available on the epitope specificity of anti-myelin oligodendrocyte glycoprotein (mog) antibodies in multiple sclerosis (ms). |
2006-07-06 |
2023-08-12 |
Not clear |
| Sjef Copray, Veerakumar Balasubramaniyan, Josien Levenga, Jorick de Bruijn, Robert Liem, Erik Boddek. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes. Stem cells (Dayton, Ohio). vol 24. issue 4. 2006-06-30. PMID:16253982. |
in view of the possible application of nscs as a source for remyelinating cell transplants in demyelinating diseases (e.g., multiple sclerosis), in vitro procedures need to be developed to drive the oligodendrocyte differentiation process. |
2006-06-30 |
2023-08-12 |
mouse |
| Richard Won. NMDA receptors expressed in oligodendrocytes. BioEssays : news and reviews in molecular, cellular and developmental biology. vol 28. issue 5. 2006-06-23. PMID:16615088. |
oligodendrocyte injury is intrinsic to the loss of function experienced in conditions ranging from cerebral palsy to spinal cord injury, focal ischaemia and multiple sclerosis. |
2006-06-23 |
2023-08-12 |
Not clear |
| Jian Rong Sheng, Maja Jagodic, Ingrid Dahlman, Kristina Becanovic, Rita Nohra, Monica Marta, Ellen Iacobaeus, Tomas Olsson, Erik Wallströ. Eae19, a new locus on rat chromosome 15 regulating experimental autoimmune encephalomyelitis. Genetics. vol 170. issue 1. 2006-06-06. PMID:15716504. |
multiple sclerosis (ms) and its animal model, myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (mog-eae), share a complex genetic predisposition with contributions from the major histocompatibility complex class ii genes and many other genes. |
2006-06-06 |
2023-08-12 |
rat |
| Joris Vanderlocht, Niels Hellings, Jerome J A Hendriks, Frank Vandenabeele, Marjan Moreels, Mieke Buntinx, Dick Hoekstra, Jack P Antel, Piet Stinisse. Leukemia inhibitory factor is produced by myelin-reactive T cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis. Journal of neuroscience research. vol 83. issue 5. 2006-06-01. PMID:16477612. |
leukemia inhibitory factor is produced by myelin-reactive t cells from multiple sclerosis patients and protects against tumor necrosis factor-alpha-induced oligodendrocyte apoptosis. |
2006-06-01 |
2023-08-12 |
Not clear |
| Jane E Libbey, Lisa K Peterson, Ikuo Tsunoda, Robert S Fujinam. Monoclonal MOG-reactive autoantibody from progressive EAE has the characteristics of a natural antibody. Journal of neuroimmunology. vol 173. issue 1-2. 2006-05-26. PMID:16469392. |
a.sw mice sensitized with myelin oligodendrocyte glycoprotein (mog)92-106 is an animal model for progressive multiple sclerosis (ms). |
2006-05-26 |
2023-08-12 |
mouse |
| Jack Ante. Oligodendrocyte/myelin injury and repair as a function of the central nervous system environment. Clinical neurology and neurosurgery. vol 108. issue 3. 2006-05-25. PMID:16384636. |
multiple sclerosis is a chronic neurologic disorder considered to result from relatively selective immune mediated injury of central nervous system (cns) myelin and/or its cell of origin, the oligodendrocyte (ogc). |
2006-05-25 |
2023-08-12 |
Not clear |